Candel Therapeutics Inc. (CADL)

NASDAQ: CADL · Real-Time Price · USD

5.27

0.38 (7.77%)

At close: May 02, 2025, 3:59 PM

5.22

-0.95%

After-hours: May 02, 2025, 05:43 PM EDT

Candel Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-55.18M	-37.94M	-18.79M	-36.12M	-17.68M	-8.24M
Depreciation & Amortization	990K	960K	778K	232K	91K	43K
Stock-Based Compensation	5.31M	3.09M	2.31M	2.96M	2.11M	400K
Other Working Capital	531K	-570K	1.28M	-1.54M	1.49M	500K
Other Non-Cash Items	21.51M	169K	-15.78M	76K	32K	2.11M
Deferred Income Tax	n/a	n/a	n/a	11.51M	4.61M	n/a
Change in Working Capital	346K	-525K	71K	-876K	1.77M	513K
Operating Cash Flow	-27.02M	-34.24M	-31.42M	-22.22M	-9.07M	-5.18M
Capital Expenditures	-16K	-457K	-1.3M	-1.83M	-1.48M	-159K
Cash Acquisitions	n/a	n/a	n/a	n/a	-39.93M	-846K
Purchase of Investments	n/a	n/a	n/a	n/a	-6K	-39.11M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	39.94M	4.37M
Other Investing Acitivies	n/a	177K	n/a	n/a	39.93M	-34.74M
Investing Cash Flow	-16K	-280K	-1.3M	-1.83M	38.45M	-35.74M
Debt Repayment	-9.17M	n/a	19.91M	n/a	460K	n/a
Common Stock Repurchased	n/a	-121K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.69M	-121K	64K	465K	30K	21.98M
Financial Cash Flow	94.28M	-121K	19.97M	71.8M	490K	21.98M
Net Cash Flow	67.24M	-34.65M	-12.74M	47.75M	29.87M	-18.94M
Free Cash Flow	-27.04M	-34.7M	-32.72M	-24.05M	-10.55M	-5.34M